Vice President, Pharmaceutical Development

Kymera Therapeutics•Watertown, MA

3d•$315,000 - $395,000

About The Position

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.

Requirements

Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, or related discipline with 18+ years of relevant pharmaceutical industry experience
Demonstrated success leading pharmaceutical development strategy from discovery through clinical development, with experience supporting commercialization readiness
Strong understanding of preformulation, biopharmaceutics, formulation development, and oral solid dose drug product manufacturing for small molecules
Deep expertise in formulation approaches for poorly soluble compounds, including application of enabling technologies to improve bioavailability and product performance
Proven track record of advancing programs through IND and clinical development milestones and contributing to successful regulatory submissions
Strong knowledge of GMP requirements, regulatory expectations, and evolving industry trends
Experience building and managing high-performing teams and external partnerships
Excellent communication and leadership skills, with the ability to effectively engage technical teams, executive leadership, external partners, and regulatory agencies

Responsibilities

Define and lead the company’s pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines
Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs
Champion innovation in formulation sciences and enabling technologies to address complex drug delivery and bioavailability challenges
Drive development and implementation of phase-appropriate drug product development and manufacturing strategies
Lead a high-performing Pharmaceutical Development team, in internal activities and management of an external network of CROs, CDMOs, and strategic partners
Establish scalable processes, operational frameworks, and best practices to support portfolio growth
Provide strategic oversight of outsourced development and manufacturing activities, ensuring quality, timelines, and technical objectives are achieved
Lead CMC-related regulatory strategy for drug product development activities, regulatory submissions and health authority interactions
Ensure compliance with applicable GMP and regulatory requirements
Represent Pharmaceutical Development in due diligence activities, external collaborations, and interactions with other functions
Contribute to risk assessment, resource prioritization, and investment decisions as a member of the Technical Operations leadership team
Foster strong cross-functional partnerships across Research, Clinical, Regulatory, Quality, Supply Chain, and Program Management to enable efficient advancement of pipeline programs